To support the health and well-being of our colleagues and community, an updated revision of the University of California Vaccine Program Policy was issued recommending that all members of the UC community follow vaccine recommendations adopted by the U.S. Centers for Disease Control and Prevention (CDC) and the California Department of Public Health (CDPH) applicable to their age, medical condition and other relevant indications.
The 2024-25 COVID-19 and flu vaccines are now readily available. Receiving an updated COVID-19 vaccine is safe and can restore protection against infections and severe disease. The flu vaccination not only reduces the incidence of flu infections, but also lessens the severity of illness in those who do contract the virus. This year, with the potential threat posed by H5N1 avian influenza, the benefits of vaccination are even more critical.
While the flu vaccine does not specifically target H5N1, having a robust immune response from the flu shot may provide some level of protection against severe complications from co-infections. In cases where individuals are infected with both influenza and H5N1, vaccination can help reduce the severity of flu symptoms, potentially improving outcomes.
By getting vaccinated, you not only protect yourself but also help safeguard those around you, especially vulnerable populations who may be at greater risk for severe disease. Contact your healthcare provider if you have any questions or concerns about the flu vaccine. Together, we can help make this season healthier for everyone.
To comply with the Flu and COVID-19 Vaccine Policy by December 1, 2024, all students, faculty and staff need to take one of these actions:
- Vaccinate: Get the 2024-25 Flu and COVID-19 vaccines and keep your records. A person is up to date with required vaccines when they have received all doses in a primary series and the most recent booster recommended by the CDC or by CDPH.
- Opt-Out: A person may formally decline vaccination by completing an opt-out form provided by coordinating with the Location Vaccine Authority, Pia Wright, pwright@ucanr.edu, on or before December 1, 2024.